Exercise Training, Insulin Resistance and Coronary Artery Disease
The Effects of Exercise Training on Insulin Resistance in Patients With Coronary Artery Disease and Insulin Resistance, the Exercise, Coronary Artery Disease and Insulin Resistance (EXCADIR) Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study was to determine the effects of exercise training on insulin resistance in subjects with coronary artery disease independent of changes in weight, diet, or the effect of an acute bout of exercise. We hypothesized that subjects with CAD and high normal or impaired glucose tolerance performing 12 weeks of aerobic exercise training while on a non weight-reducing diet, would have a greater decrease in insulin resistance than controls measured at 72 hours following their last bout of exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 coronary-artery-disease
Started Nov 1998
Shorter than P25 for phase_3 coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 25, 1998
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2000
CompletedFirst Submitted
Initial submission to the registry
December 14, 2006
CompletedFirst Posted
Study publicly available on registry
December 18, 2006
CompletedAugust 28, 2017
August 1, 2017
1.5 years
December 14, 2006
August 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insulin sensitivity
Secondary Outcomes (1)
Exercise capacity
Interventions
Eligibility Criteria
You may qualify if:
- men and women over 18 years of age
- fasting plasma glucose concentration 5.4-7.7 mmol/L
- confirmed CAD (diagnosed on the basis of a previous myocardial perfusion study or cardiac catheterization, or a history of a myocardial infarction or coronary artery angioplasty or coronary artery bypass surgery).
You may not qualify if:
- known type 1 or 2 diabetes
- clinical heart failure
- uncorrected significant valvular or congenital heart disease
- significant obstructive pulmonary disease (forced expiratory volume in 1 sec / forced vital capacity \< 0.5)
- uncontrolled hypertension (blood pressure \> 220 / 120 mm Hg)
- participation in a regular exercise program within the preceding three months
- inability to perform exercise training, atrial fibrillation
- a permanent pacemaker
- regularly used corticosteroid
- recent (\< 3 months) myocardial infarction, unstable angina, coronary artery bypass graft surgery, or coronary artery angioplasty
- run-in phase fasting blood glucose was \< 5.4 mmol/L or \> 11.1 mmol/L at 2 hours following the 75 gram oral glucose load.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hamilton Health Sciences Centre
Hamilton, Ontario, L8L2X2, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert S McKelvie, MD
McMaster Univesrity
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 14, 2006
First Posted
December 18, 2006
Study Start
November 25, 1998
Primary Completion
June 9, 2000
Study Completion
June 9, 2000
Last Updated
August 28, 2017
Record last verified: 2017-08